摘要
二甲双胍是治疗2型糖尿病的首选药物,近年来研究发现二甲双胍除了降糖作用外,还可以抗炎、抗衰老、抗肿瘤等作用。通过查阅大量文献就二甲双胍抗头颈部肿瘤的研究进展进行综述,并介绍了二甲双胍通过激活腺苷酸活化蛋白激酶(AMPK)信号通路、上调相关微小RNA(miRNAs)、抑制信号转导与转录激活因子3(STAT3)信号通路等作用机制抗头颈部肿瘤。
Metformin is the first choice for the treatment of type 2 diabetes mellitus.In recent years,studies have found that besides its hypoglycemic effect,metformin can also have anti-inflammatory,anti-aging and anti-tumor effects.This article reviews the progress of study of metformin in head and neck cancer by reviewing a large number of literatures.Metformin can inhibit head tumors by activating AMP-activated kinase(AMPK)signaling pathway,up-regulating microRNA,or inhibiting signal transducer and activator of transcription 3 signaling pathway.
作者
吴丹丹
王雪融
WU Dandan;WANG Xuerong(Kangda College of Nanjing Medical University,Lianyungang 222000,China;Nanjing Medical University School of Basic Medical Sciences,Nanjing 210000,China)
出处
《药物评价研究》
CAS
2018年第12期2376-2380,共5页
Drug Evaluation Research
基金
国家自然科学基金(30873099)
南京医科大学康达学院科研发展基金(KD2016KYJJZD005)